Join our community of traders FOR FREE!

  • Learn
  • Improve yourself
  • Get Rewards
Learn More

Airbus Group NV officially revealed that it is upgrading its 20-year old A330 jet at the Farnborough Airshow yesterday. The company is to equp the jet model with new engines in order to meet the competition of its major rival Boeing Co. and its newer 787 Dreamliner.

The Chief Executive Officer of Airbus Group NV – Mr. Tom Enders commented in the statement, which was cited by the Financial Times: “The A330 is a very important margin contributor for our group . . . with our decision to re-engine the plane, we will keep the A330 flying high for more years to come.” Mr. Enders added: “We have a very good business case, and the A330 Neo, once in service, will continue to significantly contribute to our group’s earnings.”

According to the information revealed by the company, Airbus Group NV is to invest about 1.4 billion dollars on the engine upgrade of its A330 passenger jet, aiming to prolong the life of its top-selling widebody aircraft. The company promises 14% efficiency gains by improving the aerodynamics of its A330 jets.

The announcement puts an end to the months of rumours and speculations about the A330neo model of the company. In addition, Airbus Group NV is aiming to compete better with the more technologically advanced Dreamliner of Boeing Co. that is also known for its better fuel efficiency.

As reported by the Wall Street Journal, Airbus Group NVs Chief Executive Officer Mr. Enders also shared: “With our decision to re-engine the plane, we will keep the A330 flying high for many more years to come. The “neo” in the name stands for “new engine option.”

Airbus Group NV was 0.38% up to trade at 47.32 euros per share by 8:34 GMT, marking a one-year change of +13.09%. According to the information published on the Financial Times, the 25 analysts offering 12-month price targets for Airbus Group NV have a median target of 60.00, with a high estimate of 73.00 and a low estimate of 30.50. The median estimate represents a 27.36% increase from the last price of 47.11.

TradingPedia.com is a financial media specialized in providing daily news and education covering Forex, equities and commodities. Our academies for traders cover Forex, Price Action and Social Trading.

Related News

  • Forex Market: USD/CAD daily trading outlookForex Market: USD/CAD daily trading outlook Yesterday’s trade saw USD/CAD within the range of 1.3513-1.3621. The pair closed at 1.3568, shedding 0.12% on a daily basis. It has been the first drop in the past five trading days. The daily high was an exact test of the high from December […]
  • Gulf Tensions Tighten Aluminium MarketGulf Tensions Tighten Aluminium Market Key Moments Attacks on Emirates Global Aluminium’s Al Taweelah smelter and Aluminium Bahrain’s operations have escalated aluminium supply risks. Combined outages at EGA, Alba, and earlier curtailments at Qatalum could […]
  • Hewlett Packard Enterprise appoints new Chief Financial OfficerHewlett Packard Enterprise appoints new Chief Financial Officer Hewlett Packard Enterprise said on Friday that it had appointed Marie Myers as its new Executive Vice President and Chief Financial Officer, effective January 15th 2024.Myers has been CFO of HP Inc since 2021 and has spent over 20 […]
  • Gold trading outlook: futures struggle for direction on Fed rate outlook assessmentGold trading outlook: futures struggle for direction on Fed rate outlook assessment On Wednesday (in GMT terms) gold for delivery in December traded within the range of $1,345.7-$1,363.6. Futures closed at $1,351.9, edging up 0.39% compared to Tuesday’s close. It has been the 149th gain in the past 313 trading days and also a […]
  • WTI futures hit 5-week low after bearish EIA reportWTI futures hit 5-week low after bearish EIA report West Texas Intermediate crude fell to the lowest since the beginning of December after the Energy Information Administration reported a larger-than-expected build in refined products inventories, offsetting a sixth straight decline in crude […]
  • Treace Medical stock downgraded to “Neutral” at UBSTreace Medical stock downgraded to “Neutral” at UBS Treace Medical Concepts Inc's (NASDAQ: TMCI) shares retreated more than 5% on Thursday, after UBS cut its investment rating on the stock to "Neutral".UBS cited limited visibility into Treace Medical's ability to preserve a market share […]